Effectiveness of the ten-valent pneumococcal <em>Haemophilus influenzae</em> protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age

Pneumonia

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial

Vaccine.

Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA

doi: 10.1016/j.vaccine.

RECOMMENDED

Respiratory Tract Infection

Effects of 13-valent Pneumococcal Conjugate Vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study

★ 2 Recommended by Dr Martin Frey, Faculty Member

Clin Microbiol Infect.

van Werkhoven CH, Bolkenbaas M, Huijts SM, Verheij TJM, Bonten MJM

doi: 10.1016/j.cmi.2020.09.011.

Respiratory Tract Infection

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

PLoS One.

Domínguez Á, Ciruela P, Hernández S, García-García JJ, Soldevila N, Izquierdo C, Moraga-Llop F, Díaz A, F de Sevilla M, González-Peris S, Campins M, Uriona S, Martínez-Osorio J, Solé-Ribalta A, Codina G, Esteva C, Planes AM, Muñoz-Almagro C, Salleras L

doi: 10.1371/journal.

EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited

Curr Med Res Opin.

Kamin W, Funk P, Seifert G, Zimmermann A, Lehmacher W

doi: 10.1080/03007995.

COMMENTED

Respiratory Tract Infection

Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

Lancet Respir Med.

GBD 2017 Influenza Collaborators

doi: 10.1016/S2213-

PneumoniaRespiratory Tract Infection

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine

Expert Rev Vaccines.

Wasserman M, Sings HL, Jones D, Pugh S, Moffatt M, Farkouh R

doi: 10.1080/

Respiratory Tract Infection

Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections

JAMA.

Gerber JS, Ross RK, Bryan M, Localio AR, Szymczak JE, Wasserman R, Barkman D, Odeniyi F, Conaboy K, Bell L, Zaoutis TE, Fiks AG

doi: 10.1001/jama.2017.18715.

Pneumonia

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study

Lancet Respir Med.

Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B, Celentano LP, Hanquet G; SpIDnet group.

doi: 10.1016/S2213-2600

RECOMMENDED

COPD

Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine

Vaccine.

Van Damme P, Leroux-Roels G, Vandermeulen C, De Ryck I, Tasciotti A, Dozot M, Moraschini L, Testa M, Arora AK

doi: 10.1016/j.vaccine.2019.04.041

Pneumology

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age

Related content

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial

Effects of 13-valent Pneumococcal Conjugate Vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited

Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine

Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study

Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine